Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 5 (MTND3P5) is a non-coding pseudogene sequence similar to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 (MT-ND3) gene. Unlike the MT-ND3 gene, which encodes a subunit of Complex I in the mitochondrial electron transport chain and is implicated in mitochondrial disorders such as Leigh syndrome and Leber hereditary optic neuropathy, the pseudogene does not produce a functional protein and has not been demonstrated to have biological function, disease association, or relevance as a therapeutic target. Current literature has only recently begun to profile expression of some mitochondrial pseudogenes in the context of large-scale transcriptomics or neurodegenerative disease [4]. There is no evidence MTND3P5 is a functional receptor, enzyme, transporter, or drug target. All known molecular functions, clinical significance, and druggability relate to the functional MT-ND3 protein-coding gene, not to its pseudogene relatives such as MTND3P5[1][3][2][4]. Currently, MTND3P5 should not be considered a therapeutic or biomedical target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 5 (MTND3P5).